Retour
Fourchette du Jour
100,00 €
1 001,00 €
Fourchette 52 Semaines
96,50 €
1 001,00 €
Volume
100
Moyenne 50J / 200J
103,96 €
/
108,24 €
Clôture Précédente
100,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 26,0 | 0,3 |
| P/B | 3,9 | 3,0 |
| ROE % | 16,0 | 3,7 |
| Net Margin % | 12,7 | 3,8 |
| Rev Growth 5Y % | 4,8 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,93 €
6,38 € – 7,66 €
|
1,89B | 1 |
| FY2029 |
5,70 €
5,25 € – 6,29 €
|
1,74B | 1 |
| FY2028 |
5,31 €
4,89 € – 5,86 €
|
1,65B | 1 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 4,77% annually over 5 years — modest growth
ROE of 16,00% — decent returns on equity
Generating 9,98M in free cash flow
Croissance
Revenue Growth (5Y)
4,77%
Revenue (1Y)2,62%
Earnings (1Y)5,42%
FCF Growth (3Y)-62,65%
Qualité
Return on Equity
16,00%
ROIC9,26%
Net Margin12,70%
Op. Margin15,84%
Sécurité
Debt / Equity
0,51
Current Ratio2,00
Interest Coverage29,47
Valorisation
P/E Ratio
25,96
Forward P/EN/A
P/B Ratio3,88
EV/EBITDA23,06
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,62% | Revenue Growth (3Y) | 2,22% |
| Earnings Growth (1Y) | 5,42% | Earnings Growth (3Y) | 22,32% |
| Revenue Growth (5Y) | 4,77% | Earnings Growth (5Y) | 15,26% |
| Profitability | |||
| Revenue (TTM) | 1,33B | Net Income (TTM) | 168,74M |
| ROE | 16,00% | ROA | 7,83% |
| Gross Margin | 26,54% | Operating Margin | 15,84% |
| Net Margin | 12,70% | Free Cash Flow (TTM) | 9,98M |
| ROIC | 9,26% | FCF Growth (3Y) | -62,65% |
| Safety | |||
| Debt / Equity | 0,51 | Current Ratio | 2,00 |
| Interest Coverage | 29,47 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 25,96 | Forward P/E | N/A |
| P/B Ratio | 3,88 | P/S Ratio | 3,30 |
| PEG Ratio | 5,70 | Forward PEG | N/A |
| EV/EBITDA | 23,06 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 0,23% | ||
| Market Cap | 4,38B | Enterprise Value | 4,85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,33B | 1,29B | 1,27B | 1,23B | 1,10B |
| Net Income | 168,74M | 160,06M | 112,77M | 156,49M | 95,60M |
| EPS (Diluted) | 3,85 | 3,69 | 2,62 | 3,63 | 2,20 |
| Gross Profit | 352,56M | 329,06M | 320,41M | 318,89M | 239,57M |
| Operating Income | 210,43M | 199,26M | 172,07M | 230,78M | 131,95M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,15B | 1,93B | 1,86B | 1,79B | 1,67B |
| Total Liabilities | 1,03B | 953,81M | 1,02B | 1,00B | 980,94M |
| Shareholders' Equity | 1,13B | 980,19M | 838,24M | 790,93M | 688,22M |
| Total Debt | 575,48M | 490,10M | 525,00M | 590,00M | 560,00M |
| Cash & Equivalents | 103,13M | 38,76M | 56,36M | 91,48M | 72,62M |
| Current Assets | 1,05B | 939,38M | 983,16M | 944,89M | 826,17M |
| Current Liabilities | 524,98M | 306,60M | 397,80M | 317,59M | 270,79M |